Julian Baker is an American businessman, the self-made billionaire Co-founder, Managing Partner, and President of Baker Bros. Advisors LP, one of the world's leading biotechnology-focused investment advisors. Born in 1961, his career is rooted in finance and a profound commitment to science-driven, long-term investment.

Baker graduated from Harvard University with a B.A. in Biology. His investment philosophy is legendary: he and his brother, Felix Baker (a Ph.D. in Immunology), recognized the immense, untapped financial potential of applying deep scientific diligence to the volatile biotech sector. Their model centers on taking large, concentrated stakes in companies developing transformative therapeutics.

• Baker Bros. Advisors LP (Co-founder, President & Managing Partner): The core private asset, a specialized investment adviser focused exclusively on biotechnology and life sciences equity (managing billions in assets).
• Scientific Diligence: His success is built on a unique blend of scientific and financial expertise (leveraging his brother's Ph.D. in Immunology).
• Investment Strategy: His philosophy is rooted in long-term, high-conviction investment in disruptive biopharma companies (e.g., Alexion Pharmaceuticals, Seagen).
• Philanthropy: He supports medical research and education (e.g., The Baker Institute for Animal Health at Cornell University).

Julian Baker co-founded Baker Bros. Advisors LP in 2000. His strategic genius was applying an academic, scientific rigor to investment strategy. Under his leadership, the firm became a dominant force, generating massive returns from successful long-term bets on major biopharma firms. The firm's focus on concentrated positions allows it to exert significant influence on corporate strategy and governance.

His structural contribution is tied to funding and accelerating the development of life-saving drugs in complex medical areas (oncology, rare diseases). His wealth is secured by the colossal, long-term, superior returns generated by Baker Bros.' systematic, science-driven investment strategies, cementing his legacy as a titan of biotech finance.

Julian Baker's social impact is structural, stemming from Baker Bros. Advisors' critical role in funding the high-risk, high-reward development of innovative drugs in the biotech sector. His investment capital accelerates the discovery of new therapeutics globally. His personal philanthropy supports animal health (through the Cornell institute named for the family) and medical research.

His career is a testament to the profitability of disciplined scientific diligence and long-term capital commitment in the life sciences sector.

Julian Baker maintains the professional, composed style of a financial executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects stability and immense financial authority, typical of a leader in the secretive world of hedge fund management.

Residing in New York, New York, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to investment strategy, scientific diligence, and the profitable management of biotech equity.